Albert Einstein College of Medicine
Jack and Pearl Resnick Campus
1300 Morris Park Avenue
Bronx
New York
10461
United States
Tel: 718-430-2000
Website: http://www.aecom.yu.edu/
Email: information@aecom.yu.edu
223 articles with Albert Einstein College of Medicine
-
Biohaven Pharma's NDA for its nasal spray zavegepant was accepted by the FDA, while Phase III results for its drug troriluzole to treat spinocerebellar ataxia were disappointing.
-
Albert Einstein College of Medicine Receives $4.2 Million NIH Grant to Discover Novel Markers of Early Alzheimer's Disease
4/26/2022
Diagnosing Alzheimer's disease can be a complex and time-consuming process, requiring evaluations ranging from brain scans to cognitive and lab tests to reviews of medical history and symptoms.
-
Genetic varations within the human genome is littered with breadcrumbs leading right up to new therapeutic possibilities.
-
Typical metabolic syndrome treatment includes a healthy diet, exercise, and possibly metformin, but soon, there may be a new treatment. For that and more research news, continue reading.
-
NCI-Designated Albert Einstein Cancer Center Announces Major Leadership Changes
3/29/2022
The National Cancer Institute-designated Albert Einstein Cancer Center has announced the appointment of three faculty members to key leadership positions, reflecting the center's commitment to basic science, translational, and clinical research and its core principles of diversity, equity, and inclusion.
-
In Cardio Breakthrough, Researchers Prevent Clogged Arteries with Chaperone Mediated Autophagy
3/29/2022
New research investigates the role chaperone-mediated autophagy (CMA) can play in preventing atherosclerosis, a thickening or hardening of the arteries. -
Researchers at Albert Einstein College of Medicine have cleverly developed a vaccine for pancreatic cancer by using the adaptive immunity already present in nearly all of the global population.
-
Einstein-Developed Treatment Strategy May Lead to HIV Cure
10/21/2021
Armed with a novel strategy they developed for bolstering the body's immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice—offering a path to a functional cure for HIV and other chronic viral infections.
-
Orange Grove Bio, AlleyCorp and Alexandria Venture Investments Establish Partnership with Albert Einstein College of Medicine to Support Development of Novel Therapeutics
10/21/2021
Orange Grove Bio, AlleyCorp and Alexandria Venture Investments, three industry leaders dedicated to the acceleration and growth of innovative healthcare and life science companies, announced the formation of a partnership program with Albert Einstein College of Medicine to support the development of novel therapeutics.
-
Albert Einstein College of Medicine Receives $4 Million NIH Grant To Support Diabetes Prevention and Management Research
10/20/2021
Albert Einstein College of Medicine has received a five-year, $4 million grant from the National Institutes of Health to support the New York Regional Center for Diabetes Translation Research.
-
Albert Einstein College of Medicine Awarded $5 Million for Research on Intellectual and Developmental Disabilities
9/15/2021
Albert Einstein College of Medicine has received a five-year, $5 million grant from the National Institutes of Health to support the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center, which has been at the forefront of research on normal and abnormal brain development for more than 50 years.
-
Albert Einstein College of Medicine and City University of New York Researchers Receive $14.5 Million NIH Grant to Lead HIV Studies in Central Africa
8/24/2021
Researchers at Albert Einstein College of Medicine and the City University of New York Graduate School of Public Health and Health Policy (CUNY SPH) have been awarded a five-year, $14.5 million grant from the National Institutes of Health (NIH)
-
Lauren Hackett, M.P.A., to Lead Operations at NCI-Designated Albert Einstein Cancer Center
6/24/2021
Albert Einstein Cancer Center, Albert Einstein College of Medicine, and Montefiore Health System announced that Lauren Hackett, M.P.A., has been appointed the deputy director of administration of AECC and associate vice president of cancer medicine at Montefiore Medicine.
-
Majority Of Cancer Patients With COVID-19 Have Similar Immune Response To People Without Cancer
3/22/2021
Most people with cancer who are infected by the novel coronavirus produce antibodies at a rate comparable to the rest of the population—but their ability to do so depends on their type of cancer and the treatments they've received, according to a new study by researchers at Montefiore Health System and Albert Einstein College of Medicine.
-
New Era of Partnership Between Yeshiva University and Montefiore Medicine
1/19/2021
Dr. Ari Berman and Dr. Philip Ozuah signed a new agreement between Yeshiva University and Montefiore Medicine launching a joint Yeshiva University -Albert Einstein College of Medicine B.A./B.S.-M.D. program for highly qualified high school graduates ensuring their path to an excellent medical education and an impactful career in hea
-
Stroke and Altered Mental State Increase Risk of Death for COVID-19 Patients
12/18/2020
Montefiore and Albert Einstein College of Medicine Researchers Are the First to Show this Link [18-December-2020] BRONX, N.Y. , Dec. 18, 2020 /PRNewswire/ -- People hospitalized with COVID-19 and neurological problems including stroke and confusion, have a higher risk of dying than other COVID-19 patients, according to a study published online today by researchers at
-
New COVID-19 Vaccine Unit Opens at Montefiore and Albert Einstein College of Medicine
11/23/2020
The Majority of Vaccine Trial Participants will be People of Color & Individuals Older Than 65
-
Large Study Of Hospitalized Children With COVID-19 Provides Warning Signs For Severe Illness
11/18/2020
Research led by investigators at the Children's Hospital at Montefiore, Albert Einstein College of Medicine and Yale School of Medicine, identifies symptoms that can predict how severely children will be affected by COVID-19.
-
NIH Awards $13.8 Million for Studies on the Prevention and Treatment of Alzheimer's Disease
10/5/2020
Joe Verghese, M.B.B.S., M.S., an international leader in aging and cognition research at Albert Einstein College of Medicine and Montefiore Health System, has received two grants from the National Institutes of Health totaling $13.8 million to conduct studies on pre-dementia and Alzheimer's disease.
-
Study Finds No Racial Disparity in COVID-19 Case Fatality Rates at Montefiore, When Controlling for Key Risk Factors
9/25/2020
Research by Montefiore and Albert Einstein College of Medicine found that Black and Hispanic patients had a higher occurrence of pre-existing conditions and higher rates of hospitalization